Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Abdominal aortic aneurysm (AAA), a degenerative vascular pathology characterized by permanent dilation of the aorta, is considered a chronic inflammatory disease involving innate/adaptive immunity. However, the functional role of antibody-dependent immune response against antigens present in the damaged vessel remains unresolved. We hypothesized that engagement of immunoglobulin G (IgG) Fc receptors (FcγR) by immune complexes (IC) in the aortic wall contributes to AAA development. We therefore evaluated FcγR expression in AAA lesions and analysed whether inhibition of FcγR signaling molecules (γ-chain and Syk kinase) influences AAA formation in mice.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>FcγR gene/protein expression was assessed in human and mouse AAA tissues. Experimental AAA was induced by aortic elastase perfusion in wild-type (WT) mice and γ-chain knockout (γKO) mice (devoid of activating FcγR) in combination with macrophage adoptive transfer or Syk inhibitor treatment. To verify the mechanisms of FcγR in vitro, vascular smooth muscle cells (VSMC) and macrophages were stimulated with IgG IC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>FcγR overexpression was detected in adventitia and media layers of human and mouse AAA. Elastase-perfused γKO mice exhibited a decrease in AAA incidence, aortic dilation, elastin degradation, and VSMC loss. This was associated with (1) reduced infiltrating leukocytes and immune deposits in AAA lesions, (2) inflammatory genes and metalloproteinases downregulation, (3) redox balance restoration, and (4) converse phenotype of anti-inflammatory macrophage M2 and contractile VSMC. Adoptive transfer of FcγR-expressing macrophages aggravated aneurysm in γKO mice. In vitro, FcγR deficiency attenuated inflammatory gene expression, oxidative stress, and phenotypic switch triggered by IC. Additionally, Syk inhibition prevented IC-mediated cell responses, reduced inflammation, and mitigated AAA formation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Our findings provide insight into the role and mechanisms mediating IgG-FcγR-associated inflammation and aortic wall injury in AAA, which might represent therapeutic targets against AAA disease.</p></section>

The Role of Inflammasome in Abdominal Aortic Aneurysm and Its Potential Drugs

Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets

Abdominal Aortic Aneurysm: Roles of Inflammatory Cells

The role of phosphoinositide 3-kinases in immune-inflammatory responses: potential therapeutic targets for abdominal aortic aneurysm

Potential Medication Treatment According to Pathological Mechanisms in Abdominal Aortic Aneurysm

IFI16 contributes to the pathogenesis of abdominal aortic aneurysm by regulating the caspase-1/IL-1β/MCPIP1 pathway

A role of inflammaging in aortic aneurysm: new insights from bioinformatics analysis

Understanding the Potential Function of Perivascular Adipose Tissue in Abdominal Aortic Aneurysms: Current Research Status and Future Expectation

Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model

Inflammasome Targeted Therapy as Novel Treatment Option for Aortic Aneurysms and Dissections: A Systematic Review of the Preclinical Evidence

Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development

Inflammasomes As Potential Therapeutic Targets in Atherosclerotic Cardiovascular Disease.

Macrophage Polarization and Metabolic Reprogramming in Abdominal Aortic Aneurysm

The role of long non-coding RNA in abdominal aortic aneurysm

Endothelium as a Potential Target for Treatment of Abdominal Aortic Aneurysm

Genetic association between inflammatory factors and abdominal aortic aneurysm: Insights from a genome-wide association study

Status of diagnosis and therapy of abdominal aortic aneurysms

The Role of Epigenetic Modifications in Abdominal Aortic Aneurysm Pathogenesis

Inflammation in Abdominal Aortic Aneurysm: Cause or Comorbidity?

Cellular signaling in Abdominal Aortic Aneurysm

Cellular, Molecular and Clinical Aspects of Aortic Aneurysm—Vascular Physiology and Pathophysiology